Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

CDC Fiscal Year 2019 Broad Agency Announcement

by Global Biodefense Staff
December 7, 2018
BAA Broad Agency Announcements

The Centers for Disease Control and Prevention (CDC) works with its partners to monitor health, detect and investigate health problems, conduct research to enhance and implement prevention strategies, develop and promote sound public health policies, promote healthy behaviors, foster safe and healthful environment.

The CDC is seeking proposals for improving the state-of-the-art in the following areas:

  • Address Critical Gaps in Knowledge of the Total Preventive Benefit of Influenza Vaccines
  • Compare the Immunogenicity of Alternative Influenza Vaccines and Vaccine Strategies
  • Use Modeling and Forecasting Tools to Improve the U.S. Response to Seasonal and Pandemic Influenza
  • Virology, Surveillance and Diagnosis Branch in the Influenza Division, NCIRD, CDC is seeking technologies that will improve vaccines through in-depth virus characterization and by identifying/selecting optimal candidate vaccine viruses.
  • Develop approaches to assess the level of pre-existing immunity to influenza viruses
  • Evaluate risk and diagnosis of Pertussis
  • Building the evidence base for maternal group B streptococcal vaccine decision making
  • Understanding the underlying causes of the continued increase in reported Legionnaires’ disease cases
  • Understanding carriage of Influenza
  • Assess prevalence of complement system and Meningitis
  • New Diagnostic, Sequencing, and Metagenomic Tools for AR Detection, Microbiome Analysis, and Improved Antibiotic Use
  • International Transmission, Colonization, and Prevention of AR Pathogens
  • Domestic Transmission, Colonization, and Prevention of AR Pathogens and CDI
  • Antibiotic resistant pathogens and genes in water systems and the environment and their contribution to human infections
  • Evaluating and Improving Antibiotic Use
  • Approaches to Prevention and Control of Soil Transmitted Helminth Infections

Additional topic areas of interest and submission requirements are detailed via Solicitation Number: 75D301-19-R-67835. White papers must be received electronically by 3:00 PM EST for December 17, 2018.

Tags: Editor PickInfluenzaModeling-SimulationPandemicVaccinesWhooping Cough

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC